SOBC Workshop in May 2017 at the Annual Convention of the Association for Psychological Science in Boston

A dynamic workshop featuring the Science of Behavior Change (SOBC) was held at the Association for Psychological Science (APS) on May 25, 2017, in Boston. This pre-conference workshop was entitled “Bringing an Experimental Medicine Approach to Behavior Change Research: A Hands-On Introduction to the NIH Science of Behavior Change Program and Its Method.” The half-day event was organized by the Research Coordinating Center of SOBC with presentations and hands-on guidance provided by Dr. Donald Edmondson, the Director of the Center for Behavioral Cardiovascular Health at Columbia University Medical Center, and Dr. Jennifer Sumner, an Assistant Professor of Medicine at the same institute.

read more »

 

UB’s Epstein receives lifetime achievement award

Leonard H. Epstein, an internationally recognized expert on childhood weight control, has been awarded the Hoebel Prize for Creativity by the Society for the Study of Ingestive Behavior.

The award honors a member of the society for an exceptional level of creativity and excellence in research on ingestive behavior.

read more »

 

A new show features ‘Biggest Loser’ winners who regained weight — reveals a deeper truth about weight loss

The truth hit Ryan Benson when he couldn’t fit into a seat on his son’s favorite roller coaster: He’d regained the weight he’d fought so hard to lose as a contestant on “The Biggest Loser.”

In 2005, Benson was crowned the first winner of the popular TV show, which ran for 12 years and has since ballooned into a multi-million-dollar franchise. Benson lost 122 pounds and won $250,000, but he’s since returned to his pre-show weight.

That problem wasn’t unique to Benson — a 2016 study from the National Institutes of Health (NIH) followed more than a dozen former “Biggest Losers” and  found that of the 14 people studied, 13 regained a significant portion of the weight they lost on the show. Four were heavier in 2016 than they were before they set foot on the set. read more »

 

How Behavioral Economics Can Produce Better Health Care

Consider the following.

I’m a physician at the end of more than a decade of training. I’ve dissected cadavers in anatomy lab. I’ve pored over tomes on the physiology of disease. I’ve treated thousands of patients with ailments as varied as hemorrhoids and cancer.

And yet the way I care for patients often has less to do with the medical science I’ve spent my career absorbing than with habits, environmental cues and other subtle nudges that I think little about. read more »

 

Dr. Douglas S. Mennin, PhD, Presents: Addressing the Complexity of Refractory Conditions with Mechanism-Targeted Psychosocial Intervention

Monday, May 22, 2017

2:00-3:00 pm (EST)

Traditional empirically based psychosocial treatments have been associated with considerable efficacy, especially with anxiety- and mood-related outcomes. However, sizable subgroups of individuals remain refractory to improvement. Recent advances in classification, experimental therapeutics, and precision medicine offer promise for isolating mechanisms common to many pathological conditions and developing targeted interventions, as a result. However, complex conditions with multiple overlaying dysfunctions may require multi-componential treatments to produce clinically significant and pervasive outcomes. Emotion Regulation Therapy (ERT) is an affect science based, mechanism-targeted, psychosocial intervention for chronic anxiety and mood disorders characterized by high levels of transdiagnostic negative self-referencing processes (i.e., worry, rumination, self-criticism), which are associated with poor outcome. Efficacy and preliminary mechanism data for ERT will be presented with the goal of illustrating the need for both inductive (e.g., experimental therapeutics) and deductive (i.e., honed psychosocial treatment) approaches to targeting mechanisms and improving clinical outcomes.

read more »

 

MD2K – Advancing Biomedical Discovery and Improving Health through Mobile Sensor Big Data

MD2K is one of 11 national Big Data Centers of Excellence awarded by the National Institutes of Health (NIH) as part of its Big Data-to-Knowledge initiative. The MD2K Center brings together the top brains in Computer Science, Engineering, Medicine, Behavioral Science, and Statistics, drawn from 12 universities (Cornell Tech, Georgia Tech, Northwestern, Ohio State, UCLA, UC San Diego, UC San Francisco, the University of Massachusetts Amherst, the University of Memphis, the University of Michigan, the University of Utah, and West Virginia University), and Open mHealth (a non-profit organization).
The MD2K Team is developing innovative tools to make it easier to gather, analyze and interpret health data generated by mobile and wearable sensors. The goal of the big data solutions being developed by MD2K is to reliably quantify physical, biological, behavioral, social, and environmental factors that contribute to health and disease risk. Read more here. and check out their mHealthHUB

 

Bringing an Experimental Medicine Approach to Behavior Change Research: A Hands-On Introduction to the NIH Science of Behavior Change Program and Its Method

The NIH Science Of Behavior Change (SOBC) program uses an experimental medicine approach to elucidate how behavior change works, and funders across the NIH are moving to require the use of the experimental medicine approach for mechanistic research. In this workshop, attendees will learn about SOBC and engage with the experimental medicine method in a hands-on way. (Space for this free workshop will be limited and available on a first-come, first-serve basis).

Register here for the 29th APS Annual Convention in Boston, MA, May 25-28, 2017. When you register, be sure to sign up for our free workshop. If you have already registered for the convention and would like to retroactively sign up for our workshop, please email convention@psychologicalscience.org for assistance.

 

Aligning Incentives for Sharing Clinical Trial Data

Gain insights into data sharing issues from leading experts and offer your perspective through moderated online sessions and working groups.

 

OPEN AND BALANCED VIEWPOINTS
This web event assembles a number of expert speakers and panelists to represent viewpoints of those most involved in clinical trial data sharing – researchers, clinical trial patients, and funding agencies – to ensure an open and balanced dialogue.

Register here: http://events.nejm.org/create_account1.php

 

NIH-led Effort Examines Use of Big Data for Infectious Disease Surveillance

Big data derived from electronic health records, social media, the internet and other digital sources have the potential to provide more timely and detailed information on infectious disease threats or outbreaks than traditional surveillance methods. A team of scientists led by the National Institutes of Health reviewed the growing body of research on the subject and has published its analyses in a special issue of The Journal of Infectious Diseases (link is external). read more »